20 May 2026 Zurich-based CRO InSphero, global leader in advanced 3D in vitro products and services, announces the acquisition of PhenoVista Biosciences to expand its high-content imaging and phenotypic analysis capabilities for drug discovery and safety testing. San Diego-based CRO PhenoVista Biosciences, Inc., is a leading provider in high-content imaging, cell painting, and functional cellular analysis for the biopharmaceutical industry. Their diverse repertoire includ